Girshick Birgit's Form 4 filing
Charles River Laboratories International, Inc.CRL · filed Feb 21, 2025
- Accession no.
- 0001127602-25-006251
- Filed
- Feb 21, 2025
- Trade date
- Feb 20, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market purchases total $249.2K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Girshick BirgitCIK 0001732091 | Officer (Corporate Executive VP & COO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 20, 2025 | Common Stock | PPurchaseAcquired | +1,514 | $164.63 | +$249,249.82 | 55,058 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.